Press Releases

Press Releases

Kite Pharma, Inc. today announced the appointment of Paul L. Jenkinson as Chief Financial Officer, reporting to Arie Belldegrun, M.D., FACS, Kite’s Chairman, President, and Chief Executive Officer. Mr. Jenkinson succeeds Cynthia M. Butitta, who continues in her role as Kite’s Chief Operating Officer. Mr. Jenkinson and Ms. Butitta are…

Press Releases

GNT Pharma (“GNTP”) announced that the Korea Ministry of Food and Drug Safety has approved the company's Investigational New Drug (IND) application to initiate a Phase II clinical study of Neu2000 in ischemic stroke patients receiving endovascular therapy, a new interventional treatment to recanalize arteries and salvage the ischemic brain,…

Tuesday, May 17, 2016
Press Releases

In the run up to our 14th Annual Pharma IT Congress in September, we are delighted to invite you to join our free pre-congress webinars on the theme: "Real-World Data Updates, Novel IT Solutions & The Mobile Workplace" Tuesday 7th June 2016 | 2pm GMT Presentation: Leveraging Real-World Data In…

Press Releases

Mundipharma Medical Company Limited and the independent associated company, Purdue Pharma L.P., today announced that, following completion of Phase II studies, they have exercised their option and taken over full responsibility from Laboratorios Esteve, S.A.U (ESTEVE) for the clinical, regulatory and commercial development of a potential first-in-class sigma-1 antagonist (S1A…

Press Releases

Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today the U.S. Patent and Trademark Office has issued a Notice of Allowance to the Company for claims covering important treatment methodologies, which form the basis of its lead drug candidate, KIT-302, and that ameliorate celecoxib-induced elevation of…

Press Releases

BeyondSpring Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, including its Phase III immuno-oncology compound and strong pipeline in collaboration with the Fred Hutchinson Cancer Research Center, today announced that Chief Medical Officer Ramon Mohanlal, M.D., Ph.D., served on a prominent panel at NewYorkBIO…

Press Releases

Sophiris Bio Inc., a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that it has engaged Oppenheimer & Co. Inc. as its financial advisor to assist with evaluation of strategic alternatives to advance the development of topsalysin and enhance shareholder value, including potential partnering arrangements,…

Press Releases

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, today announced that its pharmaceutical facilities and analytical and stability testing facilities in Shanghai passed the European Medicines Agency (EMA)inspection for GMP compliance, with "no critical and no major…

Press Releases

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that an official Notification of Granting Patent Right was issued for the Company's patent for its invention titled "Methods and Compositions for Oral Administrations of Proteins" by the State Intellectual Property Office of the People's Republic of China.…

Press Releases

BioDelivery Sciences International, Inc. and Collegium Pharmaceutical, Inc. today announced the signing of a licensing agreement under which BDSI is granting the exclusive rights to develop and commercialize ONSOLIS® (fentanyl buccal soluble film) in the U.S. to Collegium. ONSOLIS is an opioid agonist indicated for the management of breakthrough pain…